TIVC Tivic Health Systems, Inc. Insider Trading

Director Bolton Sheryle purchases 10,000 shares of TIVC at $1.04; company down -33.7% revenue YoY with $-2.6M net loss

Bolton Sheryle acquired 10,000 shares at $1.04 on 2026-04-15, establishing an initial position in Tivic Health Systems. The transaction occurs in the context of severe operational stress: the company reported -33.7% annual revenue contraction and a full-year net loss of $-2.6M. The stock is currently trading at $1.13, -84.2% below its 52-week high of $7.13, though it has gained 22.8% over the past 30 days. An insider director purchase at depressed levels following substantial revenue decline and persistent unprofitability warrants scrutiny into her access to forward-looking information or confidence rationale.

Director Valauri Christina Rizopoulos buys 19,000 shares of TIVC at $0.95; stock down -86.0% from 52-week high at $1.00 current

Valauri Christina Rizopoulos initiated a new position in Tivic Health Systems with a purchase of 19,000 shares at $0.95 on 2026-04-01, representing an initial holding for this director. The transaction occurs in the context of significant stock deterioration: the stock trades 86.0% below its 52-week high of $7.13 and is currently at $1.00. Operationally, the company faces material headwinds with net income of $-2.6M in the latest quarter, full-year unprofitability, and annual revenue decline of -33.7% year-over-year against quarterly revenue of only $146.0K. A director's initial investment in a distressed financial situation warrants investor attention to understand the rationale and any non-public information supporting the purchase decision.